Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia.

Autor: Fomina DS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; First Sechenov Moscow State Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia., Lysenko MA; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Healthcare, Moscow, Russia., Beloglazova IP; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Healthcare, Moscow, Russia., Mutovina ZY; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; Federal State Institution of Additional Professional Education 'Central State Medical Academy' of the President of the Russian Federation, Moscow, Russia., Poteshkina NG; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Healthcare, Moscow, Russia., Samsonova IV; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Kruglova TS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Chernov AA; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; Russian Medical Academy of Continuing Professional Education, Moscow, Russia., Karaulov AV; First Sechenov Moscow State Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.

Publikováno v: Pathogens & immunity [Pathog Immun] 2020 Oct 02; Vol. 5 (1), pp. 327-341. Date of Electronic Publication: 2020 Oct 02 (Print Publication: 2020).